Avelo, VIVOLTA, and BLINK (BreathCounts Consortium)

About Avelo, VIVOLTA, and BLINK (BreathCounts Consortium)

Avelo is dedicated to revolutionizing tuberculosis and pneumonia diagnostics through innovative breath sampling technology. Their mission is to address global health threats by providing non-invasive, accurate diagnostic solutions to save lives, reduce healthcare costs, and combat antimicrobial resistance.

Products & Services

AveloMask:A breath aerosol collector kit that includes a special mask and buffer tube. It is non-invasive, easy to use, captures disease-causing viruses and bacteria from the lungs, and works with existing molecular tests for diagnosis.

Specialties

Breath sampling technology Tuberculosis diagnostics Pneumonia diagnostics Non-invasive diagnostics Respiratory infection testing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant (Eurostars) T: - FT: Grant (Eurostars)	A: 1600000 MR: - FA: €1.5M FAN: 1600000	D: 2023-10-26 FD: 2023-10-26	1 investors

Grant (Eurostars) Latest

2023-10-26

$1.6M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Melanie Aregger

CEO & Co-Founder

LinkedIn (Pro only)

T

Tobias Broger

CTO & Co-Founder

LinkedIn (Pro only)

K

Katie Tiseo

Clinical Study & Project Manager

LinkedIn (Pro only)

H

Harshitha Santhosh Kumar

Senior Scientist - Molecular Assays

H

Helge Lubenow

In-Vitro Diagnostics and Commercialization Expert

W

Wolfgang Mach

Clinical Laboratory and Business Development Expert

View 6 more team members with Pro

Unlock Full Team Directory

Recent News